Projects per year
Fingerprint
Dive into the research topics where Agata Natasza Burska is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 2 Active
-
Nanotechnology enhanced oxidative drug treatment of 3D culture of KRAS mutant colorectal cancer cell lines
Burska, A. N., Sarbassov, D., Paunov, V. & Baumuratov, A.
2/1/23 → 12/31/25
Project: Government
-
The Vitamin C Enantiomers Possess a Comparable Potency in the Induction of Oxidative Stress in Cancer Cells but Differ in Their Toxicity
Begimbetova, D., Burska, A. N., Baltabekova, A., Kussainova, A., Kukanova, A., Fazyl, F., Ibragimova, M., Manekenova, K., Makishev, A., Bersimbaev, R. I. & Sarbassov, D. D., Mar 2024, In: International journal of molecular sciences. 25, 5, 2531.Research output: Contribution to journal › Article › peer-review
Open Access1 Citation (Scopus) -
2022 EULAR points to consider for the measurement, reporting and application of IFN-I pathway activation assays in clinical research and practice
Rodríguez-Carrio, J., Burska, A., Conaghan, P. G., Dik, W. A., Biesen, R., Eloranta, M. L., Cavalli, G., Visser, M., Boumpas, D. T., Bertsias, G., Wahren-Herlenius, M., Rehwinkel, J., Frémond, M. L., Crow, M. K., Rönnblom, L., Versnel, M. A. & Vital, E. M., Jun 1 2023, In: Annals of the Rheumatic Diseases. 82, 6, p. 754-762 9 p.Research output: Contribution to journal › Article › peer-review
Open Access17 Citations (Scopus) -
Association between type I interferon pathway activation and clinical outcomes in rheumatic and musculoskeletal diseases: a systematic literature review informing EULAR points to consider
Rodríguez-Carrio, J., Burska, A., Conaghan, P. G., Dik, W. A., Biesen, R., Eloranta, M. L., Cavalli, G., Visser, M., Boumpas, D. T., Bertsias, G., Wahren-Herlenius, M., Rehwinkel, J., Frémond, M. L., Crow, M. K., Ronnblom, L., Vital, E. & Versnel, M., Mar 7 2023, In: RMD Open. 9, 1, e002864.Research output: Contribution to journal › Article › peer-review
Open Access18 Citations (Scopus) -
Gene Expression and Autoantibody Analysis Revealing Distinct Ancestry-Specific Profiles Associated With Response to Rituximab in Refractory Systemic Lupus Erythematosus
The MASTERPLANS Consortium, May 2023, In: Arthritis and Rheumatology. 75, 5, p. 697-710 14 p.Research output: Contribution to journal › Article › peer-review
Open Access10 Citations (Scopus) -
Type I interferon pathway assays in studies of rheumatic and musculoskeletal diseases: a systematic literature review informing EULAR points to consider
Burska, A., Rodríguez-Carrio, J., Biesen, R., Dik, W. A., Eloranta, M. L., Cavalli, G., Visser, M., Boumpas, D. T., Bertsias, G., Wahren-Herlenius, M., Rehwinkel, J., Frémond, M. L., Crow, M. K., Ronnblom, L., Conaghan, P. G., Versnel, M. & Vital, E., Mar 2 2023, In: RMD Open. 9, 1, e002876.Research output: Contribution to journal › Article › peer-review
Open Access9 Citations (Scopus)